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Abstract
Human  plexus  injuries  often  include  the  avulsion  of  one  or  more  ventral  roots,  resulting  in
debilitating  conditions.  In  this  study the  effects  of  undifferentiated  murine  iPSCs  on damaged
motoneurons were investigated following avulsion of the lumbar 4 (L4)  ventral  root,  an injury
known to induce the death of the majority of the affected motoneurons. Avulsion and reimplantation
of the L4 ventral root (AR procedure) was accompanied by the transplantation of murine iPSCs into
the  injured  spinal  cord  segment  in  rats.  Control  animals  underwent  ventral  root  avulsion  and
reimplantation, but did not receive iPSCs.  The grafted iPSCs induced an improved reinnervation of
the reimplanted ventral root by the host motoneurons as compared with the controls  (number of
retrogradely labeled motoneurons: 503 ± 38  [AR+iPSCs group] vs 48 ± 6 [controls, AR group]).
Morphological reinnervation resulted in a functional recovery, i.e.  the grafted animals exhibited
more motor units in their reinnervated hind limb muscles, which produced a greater force than that
in the controls (50 ± 2.1% vs 11.9 ± 4.2% maximal tetanic tension [% ratio of operated/intact side]).
Grafting of undifferentiated iPCSs downregulated the astroglial activation within the L4 segment.
The grafted cells differentiated into neurons and astrocytes in the injured cord. The grafted iPSCs,
host neurons and glia were found to produce the cytokines and neurotrophic factors MIP-1a, IL-10,
GDNF and NT-4. These findings suggest that, following ventral root avulsion injury, iPSCs are able
to  induce  motoneuron  survival  and  regeneration  through  combined  neurotrophic  and  cytokine
modulatory effects.
Introduction
Following an injury or various diseases afflicting the cell body or axon of the motoneuron, spinal
motoneurons  become increasingly vulnerable  to  glutamate  cytotoxicity  (McNaught  and Brown,
1998; Spalloni et al., 2013). Avulsion of one or more ventral roots, which typically occurs in plexus
injuries, induces the death of motoneurons in consequence of the excessive amounts of glutamate
loaded onto the affected neurons (Carlstedt, 2008). Glutamate activates the N-methyl-D-aspartate
receptors, leading to an excessive influx of Ca2+ into the damaged cells and to the death of the vast
majority of the affected motoneurons ( Koliatsos et al., 1994  ;  Nogradi and Vrbova, 2001  ;  Nogradi et
al., 2007  ). Damaged motoneurons do not die immediately after the injury, and the window of 10-12
days between the injury and the motoneuron death can be successfully used to rescue the injured
motoneurons (Nogradi et al., 2007; Pinter et al., 2010]. Reimplantation of the avulsed ventral root is
the  primary  requirement  for  regeneration  of  the  motor  axons,  but  in  a  typical  situation  few
motoneurons  are  able  to  survive  and  reinnervate  peripheral  targets  without  additional
neuroprotective support (Carlstedt et al., 1990; Carlstedt, 2008; Nogradi and Vrbova, 1996). These
neuroprotective strategies involve the use of neurotrophic factors, Na+  channel blockers/glutamate
release inhibitors and native or genetically enginereed stem cells (Blits et al., 2004; Eggers et al.,
2008;  Eggers et  al.,  2013;  Nogradi and Vrbova,  2001;  Novikov et  al.,  1997;  Wu et al.,  2003).
However, only Na+  channel blockers/glutamate release inhibitors, such as  riluzole have proved
effective from the aspects of inducing both motoneuron survival and functional reinnervation, while
neurotrophic factors and stem/progenitor cell therapies have failed to induce the axonal outgrowth
of otherwise surviving motoneuron populations (Blits et al., 2004; Eggers et al., 2013; Pinter et al.,
2010).  The use of embryonic stem cells is otherwise complicated by ethical concerns. 
Yamanaka et al. have reported that murine and human skin fibroblasts can be reprogrammed to a
pluripotent state through application of the transcription factors KLF4, SOX2, OCT4 and c-MYC
(Okita et al., 2007; Takahashi and Yamanaka, 2006; Takahashi et al., 2007). Due to the availability
of species- or individual-specific induced pluripotent stem cells (iPSCs) not only does this suggest a
new therapeutic potential for cell rescue, but the ethical concerns can be minimized, too. Indeed,
recent studies have shown that iPSCs or their derivatives have neuroprotective effect on certain
populations of central nervous system (CNS) neurons and are able, to a certain extent to replace lost
neurons or glial cells within the CNS (Chen et al., 2010; Fujimoto et al., 2012; Hargus et al., 2010;
Tsuji et al., 2010). 
Here, we investigated whether mouse iPSCs  grafted into the injured rat spinal cord immediately
after ventral root avulsion and reimplantation  are able to rescue injured motoneurons and induce
reinnervation of the reimplanted ventral root by the regenerating motor axons. A further aim of this
study was to reveal the differentiation pattern of the grafted iPSCs and the mechanism of action by
which they induced motoneuron survival and functional reinnervation in the target skeletal muscles.
Materials and Methods
Cell culture
Murine embryonic fibroblasts (MEFs) obtained by a standard protocol from a murine fetus 13 days
post coitum were cultured in FM medium (DMEM-GlutamaxI supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin/streptomycin) (Robertson, 1987). The MEFs at passage one were
used to generate iPSCs,- and those at passage three to generate feeder cells treated with mitomycin
C (Sigma-Aldrich, St Lake, MO, USA).
iPSCs  and  enhanced  green  fluorescent  protein  (eGFP) containing  iPSCs  (eGFP-iPSCs)  were
cultured in  embryonic stem cell  medium (ESC medium:  DMEM-GlutamaxI supplemented with
15% ESC qualified FBS (SLI Ltd, West Sussex, UK), 1 mM β-mercaptoethanol, 1% non-essential
amino acids (Sigma-Aldrich, St Lake, MO, USA), 10 U/ml penicillin, 10 µg/ml streptomycin and
1000 U/ml leukemia inhibitory factor (ESGRO, Chemicon/Millipore, Billerica, MA, USA). 
Generation of iPSCs and eGFP-iPSCs 
The generation of iPSCs was described in detail elsewhere (Nemes et al., 201  4). Briefly: MEFs
were seeded at 5x104 cells per well in a 6-well plate coated with gelatin in FM medium. On the
following day, the medium was replaced with ESC medium supplemented with valproic acid (final
concentration 1 mM) and the purified recombinant reprogramming protein cocktail (Oct4, Sox2,
Klf4 and c-Myc) at a final concentration of 8 µg/ml. After a 12-h incubation, the medium was
changed to normal ESC medium and the cells were cultured for 36 h. The cells were treated 4 times
with the protein cocktail at intervals of 48 h. On day 9, the cells were transferred to feeder-coated
10-cm dishes and cultured further until ESC-like colonies appeared. The medium was refreshed
every second day.
Under the control of the elongation factor-1-alpha (EF1α) promoter, the eGFP reporter protein was
introduced into  the  iPSCs by lentiviral  transduction.  The eGFP-expressing  iPSC colonies  were
identified under a fluorescent microscope and picked individually. Only those iPSC colonies were
used for transplantation that uniformly expressed the eGFP.
Neural differentiation assay
Differentiation  of  mouse  iPSCs  and  eGFP-iPSCs  towards  neural  lineages  was  performed  via
embryonic body (EB) formation in suspension in accordance with the previously published protocol
(Bibel  et  al.,  2004)  Briefly,  iPSCs  and  eGFP-iPSCs  were  dissociated  with  0.05% trypsin  and
4.5x106  cells in 15 ml medium were seeded onto a non-adherent 10 cm bacterial dish (Greiner)
coated with 2-Hydroxyethyl methacrylate (2-HEMA, Sigma-Aldrich) and cultured at 37C±2C,
5±1% CO2 for 8 days. The medium was refreshed every second day. From day 4, the differentiation
medium was supplemented with retinoic acid (5 µM final concentration). On day 8, the EBs were
dissociated with 0.25% Trypsin; and 2x105 cells/cm2 in Medium A (3 mg/ml Glucose, 3 mg/ml
AlbuMaxI,  10 U/ml Penicillin,  10 µl/ml Streptomycin, 1% N2 supplement and 10 ng/ml bFGF
(freshly  added)  in  DMEM/F12)  were  seeded  on  polyornithine/laminin  coated  coverslips.  The
medium  was  refreshed  on  day  9.  From day  10,  the  cells  were  cultured  in  Medium  B  (50%
DMEM/F12, 50% Neurobasal Medium, 1 mM GlutaMaxI, 3 mg/ml AlbuMaxI, 10 U/ml Penicillin,
10 µg/ml Streptomycin, 0.5% N2 supplement and 1% B27 supplement). The cells were cultured
until day 12.
Ventral root avulsion–reimplantation (AR procedure) and transplantation of iPSCs
All  the  operations  were  carried  out  under  deep  ketamine-xylazine  anesthesia  (ketamine
hydrochloride, 110 mg/kg body weight; xylazine (Rompun) 12 mg/kg body weight) with sterile
precautions. To maintain the body temperature at 37.0±0.5 °C, the rats were kept on a heating pad
(Supertech Ltd, Pécs, Hungary) during the surgery.  Laminectomy was performed at the level of
T13–L1, the dura was opened and the left L4 ventral root was pulled out, leaving the dorsal roots
intact. The cut end of the ventral root was then inserted into the ventrolateral part of the spinal cord
and 3 x 105 iPSCs were injected into the caudal part of the L4 segment (AR+iPSCs group). The
spinal cord was covered with the remaining dura,  the wound was closed and the animals were
allowed to recover. In the control experiments (AR group), the L4 ventral root was avulsed and
reimplanted without iPSC grafts. Animals were examined after a survival time of 3, 7, 12, 16 or 21
days or 3 months. Appropriate care was taken to minimize pain and discomfort.
Retrograde labeling 
Three months after the surgery 5 animals per group and 5 intact animals were deeply anesthetized
as described above. On the operated side the ventral ramus of the left L4 spinal nerve was cut and
the proximal stump of the nerve was covered with a few Fast Blue crystals. Four days after the
application of this fluorescent dye, the animals were reanesthetized and were perfused transcardially
with 4% paraformaldehyde in 0.1 M phosphate buffer.
RNA isolation and cDNA synthesis
Spinal cord samples were stored in RNAlater (Qiagen) at -20 °C. For tissue lysis, the samples were
placed in 2-ml Eppendorf tubes, and 600 μl of RLT buffer and a 5-mm stainless steel bead were
added to each tube. The tissues were lysed for 4 min at 30 Hz by a TissueLyser instrument (Qiagen).
The lysates were spun for 3 min at 13.000 rpm. Total  RNA was purified by using the RNeasy Mini
Kit  (Qiagen)  according  to  the  manufacturer’s instructions.  RNA concentration  and purity  were
measured  by  Nanodrop  (Thermo  Scientific).  1  μg  of  RNA  was  digested  with  RQ1  DNase
(Promega) and reverse-transcribed with SuperScript III RT enzyme and oligo(dT)20 primers (Life
Technologies).  
Semiquantitative polymerase chain reaction (PCR)
For quantification of the PCR products, 4 spinal cord samples from 4 different treatment groups
were analyzed (avulsed, non-injected spinal cords 3 and 7 days after operation; and avulsed, iPSC-
injected spinal cords 3 and 7 days after the operation). The spinal cord cDNA was amplified by
using gene-specific primers that recognize both murine and rat gene products. The primer sequences
used are listed in Supplementary Table 1. The reaction was carried out in GoTaq Green Master Mix
(Promega) in Veriti Thermal Cycler (Applied Biosystems) with an initial denaturation step at 95° C
for 2 min, and 22-38 cycles of denaturation at 95 °C for 45 s, annealing at 60 °C for 45 s and
extension at 72 °C for 30 s. The PCR products were run in ethidium bromide-containing 1.5%
agarose gels,  and pictures  were  taken with the  Gel  Logic 1500 Imaging System (Kodak).  The
intensities  of  the  bands  were  quantified  with  ImageJ  Software  (imagej.nih.gov/ij).  The  band
intensity of each gene product was normalized to that of the housekeeping gene GAPDH. The data
for the replicates (n=4) were averaged, and the standard errors of the mean (SEM) are depicted as
error bars in the diagrams.
Immunohistochemistry
For  the  cultured  iPSCs,  cells  were  permeabilized  in  PBS containing  0.1% Triton  X-100 for  5
minutes and blocked in 5% bovine serum albumin for 1 hour at room temperature (RT). The cells
were than incubated 1 hour at RT with the following primary antibodies: monoclonal anti-nestin
(Developmental  Studies  Hybridoma  Bank,  1:100),  rabbit  neuronal  class  III   tubulin  antibody
(Covance, 1:2000), mouse anti Oct 4 (Santa-Cruz; 1:100), mouse anti-SSEA1 (Santa Cruz; 1:100),
goat anti-Sox2 (Santa Cruz; 1:50), goat anti-Nanog (R&D Systems; 1:50). The primary antibodies
were visualized with AlexaFluor 647 donkey anti-rabbit IgG (H+L), AlexaFluor 594 donkey anti-
mouse (H+L) and Alexa Fluor 594 donkey anti-goat IgG (H+L) (1:2000). Finally the cells were
incubated with DAPI (4',6-diamidino-2-phenylindole; 0.2 µg/ml final concentration) in PBS for 20
minutes at RT. 
For the spinal cords, 25 µm transverse sections were cut on a cryostat (Leica CM 1850, Leica
GmbH, Germany) and mounted onto gelatin-coated glass slides. Nonspecific binding sites were
subsequently  blocked  with  3% normal  donkey,  goat  or  horse  serum.  Primary  antibodies  were
incubated overnight at  4  oC, washed, and then incubated with fluorescent-conjugated secondary
antibodies for 1 h at room temperature. The following primary antibodies were used: anti-rabbit
brain-derived nerve growth factor (BDNF), anti-neuron-specific beta III tubulin, anti-rabbit glial-
derived nerve growth factor (GDNF) (1:200; all  from Abcam), anti-mouse GFAP (1:100; Santa
Cruz Biotechnology, Inc, CA), chicken anti-green fluorescent protein polyclonal (GFP) (1:2000;
Chemicon),  biotinylated  Griffonia  (Bandeira)  Simplicifolia isolectin  B4  (for
microglia/macrophages,  1:200;  Vector),  anti-rat  IL-1-alpha,  anti-rat  IL-6,  anti-rat  IL-10,  anti-rat
TNF-alpha,  anti-rat  MIP-1  alpha  (1:200;  all  from Abbiotec,  San Diego,  CA),  goat  anti-choline
acetyltransferase (1:200; Millipore, Billerica, MA), anti-mouse M6 (mouse-specific neuron marker,
1:400; DSHB, Iowa), anti-mouse M2 (mouse-specific astrocyte marker, 1:400; DSHB, Iowa City,
IA), anti-mouse MOG (mouse-specific oligodendrocyte marker, 1:50; R&D Systems, Minneapolis,
MN) anti-rabbit neurotrophin 4/5 (1:200; Abbiotec, San Diego, CA) and SSEA-1 (stage-specific
mouse  embryonic  antigen,  1:400;  DSHB,  Iowa  City,  IA).  Secondary  antibodies  were  used  as
follows: Alexa Fluor 594 donkey anti-rat, Alexa Fluor 546 goat anti-rabbit, Alexa Fluor 546 donkey
anti-goat, Alexa Fluor 488 goat anti-chicken, streptavidin Alexa Fluor 405 conjugate, streptavidin
Alexa Fluor 546 conjugate, streptavidin Alexa Fluor 488 conjugate (1:400; all from Invitrogen),
biotinylated anti-goat IgG (H+L) and biotinylated anti-mouse IgG (H+L). To validate TNF-alpha
and IL-1-alpha immunohistochemistry, Mg3HeLa cells transfected with a TNF-alpha plasmid (kind
gift from Ernő Duda, at the Biological Research Centre, Szeged, Hungary) and rat testis were used,
respectively.
Fluorescent signals were detected in an Olympus BX50 epifluorescence microscope equipped with
a DP70 digital camera (Olympus Ltd, Tokyo, Japan). Confocal microscopic images were obtained
with an Olympus FluoView® FV10i compact confocal microscope.
Quantification of differentiation process of the grafted iPSCs
To  quantify  the  differentation  of  grafted  iPSCs,  we  processed  cross  sections  of  spinal  cord
containing  grafted  cells  for  immunohistochemistry  3,  7,  10,  12,  and  16  days  after  the
transplantation. For each cell marker, we randomly selected three tissue sections that were 100–150
µm apart. At 120x magnification of the confocal microscope (square area of 102 µm x 102 µm), we
first counted the number of GFP/DAPI-positive cells (for SSEA-1) and DAPI-positive cells (for M2
and M6) in 3 random fields per section. Next, we determined the number of the GFP-positive cells
colabeled with SSEA-1. We only counted those GFP-positive cell bodies that contained a nucleus
(identified with DAPI). Then, the percentage of co-labeled GFP/cell marker was calculated for each
rat (n=4). For M2 and M6, we determined the number of M2- or M6-positive cells as percentage of
DAPI-positive cells in the graft. Quantification of grafted cells that produced factors (NT-4, GDNF,
IL-10 and MIP-1a) was performed as described for the SSEA-1.
Cell counts
The numbers of retrogradely labeled cells were determined on 25-µm-thick serial cryostat sections.
To avoid double counting of neurons present in two consecutive sections, the retrogradely labeled
neurons were mapped with the aid of an Olympus (Olympus Ltd, Tokyo, Japan) drawing tube, and
their locations were compared with those of labeled neurons in the previous section (Nógrádi et al.,
2007; Pintér et al., 2010). All the sections from the L4 motoneuron pool were used.
Quantification of astrocyte and microglia/macrophage densities
To assess the densities of GFAP-positive astrocytes and GSA-B4-positive microglia/macrophages in
injured and grafted ventral horns, we photographed injured, grafted and intact, randomly chosen
frames of the ventral horns from each rat at a primary magnification of 10x, using an Olympus
FluoView® FV10i confocal microscope at distances of 0.5, 1, 1.5 and 2 mm rostrally and caudally
to  the  reimplanted  ventral  root  (n=5/group).  To  quantify  the  densities  of  GSA-B4-positive
microglia/macrophages in the graft, we randomly selected three tissue sections being 100–150 µm
apart and photographed the graft from each rat at a primary magnification of 40x, using an Olympus
FluoView® FV10i confocal microscope. Using ImageJ Software (NIH), we measured the relative
density of GFAP and GSA-B4 immunoreactivity in the samples. The background/autofluorescence
of unstained samples as reference intensity was then subtracted from the intensity of the injured,
grafted and intact ventral horns and from the grafts to determine the final density. The GFAP and
GSA-B4 intensity of the injured and grafted ventral horns and that of the graft was then divided by
the intensity of the GFAP and/or GSA-B4 reactivity of the contralateral intact ventral horns.  As
GSA-B4 labels the endothelial cells of some capillaries, the density of the capillaries was deducted
from the total  densities. Furthermore,  automatic thresholding was performed for each image by
using the NIH ImageJ software to determine the threshold for the specific signal. After the threshold
had been set, the density above the threshold was quantified.
Muscle tension recording
The animals that were selected for tension recording (n=5 both in the control and in the grafted
group) were anesthetized with ketamine-xylazine at the end of the 3-month survival period and the
tibialis anterior (TA) and extensor digitorum longus (EDL) muscles of both the reinnervated and the
contralateral control hindlimb were prepared for tension recording. These muscles were chosen for
tension  recording  as  the  motoneurons  innervating  them  are  situated  mainly  in  the  L4  spinal
segment.   The muscles of the contralateral  leg were regarded as suitable controls because their
tension increased with age in a similar way to that of the muscles in normal, unoperated animals.
The distal tendons were dissected free and attached to strain gauges, and the exposed parts of the
muscles were kept moist with Krebs' saline solution. Isometric contractions were then elicited from
the muscles by stimulating the ventral ramus of the L4 spinal nerve with bipolar electrodes.  The
length of each muscle was adjusted so as to produce maximal twitch tension. Single twitch and
tetanic (40-100 Hz) contractions were displayed and recorded on a computer;  all the additional
recording  hardware  and  software  were  developed  by  Supertech  Ltd  (Pécs,  Hungary;  system
“Kellényi”).  Maximal tetanic tension was achieved at a stimulation frequency of about 100 Hz.  An
estimate of the numbers of motor axons supplying the muscles was obtained by subjecting the L4
spinal nerve to stimuli of increasing intensity and recording the stepwise increments in the twitch
contractions. 
Statistical analysis
The  paired  T test was  used  to  compare  the  groups  of  data.  Data  are  reported  throughout  the
manuscript as mean ± S.E.M. The differences of multiple groups were computed according to one-
way ANOVA followed by Tukey's  post hoc test. Probability values of  p < 0.05 were regarded as
significant for all analyses.
Results
Characterization of the eGFP-iPSC line
The pluripotency of the parental iPSC line was verified by in vitro and in vivo methods (Nemes et
al., 2014). The expression pattern of different markers was verified by immunocytochemistry. The
cells expressed the major pluripotency markers: SSEA1, Oct4, Sox2 and Nanog (Fig. S1A).  
As no difference in the morphology and the growth dynamics between the parental cell line and the
eGFP-iPSCs was observed, we verified the neural differentiation capability of the eGFP-iPSCs. The
transduced cells were positive for nestin, the neural progenitor cell marker, and for neural class III
-Tubulin (Tuj1),  a neuron marker (Fig.  S1B). During the in vitro differentiation we could not
detect significant loss of the eGFP signal.
iPSC grafts improve motoneuron survival and reinnervation of denervated muscles
The ability of iPSCs to rescue damaged motoneurons otherwise destined to die was investigated in
long-term studies,  allowing the  animals  to  survive  for  3  months  after  the  avulsion  injury. The
number of resident motoneurons in the intact L4 motoneuron pool was first assessed by retrograde
labeling of the ventral ramus of the L4 spinal nerve. The average number of retrogradely labeled
motoneurons  was  1164±29.  The motoneurons  were  localized  mainly in  the  lateral  motoneuron
column of the L4 spinal segment. Three months after the avulsion and reimplantation in the control
animals (the AR group, whose L4 ventral root was avulsed and reimplanted, but which received no
iPSC graft),   48±6 retrogradely labeled motoneurons were detected.  In contrast,  a significantly
higher  number  of  reinnervating  motoneurons  (503  ±  38)  was  observed  when  the  iPSCs  were
transplanted immediately after ventral root reimplantation (AR+iPSCs animals; Figs. 1B,C). 
In order to determine the proportion of surviving motoneurons that were able to send their axons
into  the  reimplanted  L4  ventral  root,  the  number  of  choline  acetyltransferase  (ChAT)-positive
motoneurons labeled with the fluorescent retrograde tracer Fast Blue (FB) was compared with the
number of surviving ChAT-positive motoneurons in the injured L4 segment on the operated side. In
the  control  rats,  the  percentage  of  reinnervating  FB-positive  motoneurons  within  the  surviving
ChAT-positive motor pool was only 14 ± 1.8%, whereas in the grafted animals this ratio was much
higher, at 61 ± 3.3%, indicating that more than half of the surviving motoneurons in the AR+iPSCs
group were able to maintain a long axon in the L4 reimplanted ventral root and peripheral nerve
pathways (Fig. 1D).
The  question  of  whether  the  iPSC  grafts  promoted  the  survival  of  resident  motoneurons  was
investigated by comparing the number of ChAT-positive motoneurons on the operated side with that
on the intact side. In the AR group, the proportion of surviving motoneurons on the operated side
was 40 ± 2,5%, whereas in the AR+iPSCs animals it was 72 ± 5.4%, indicating that the treatment
with iPSCs significantly improved the survival of the injured motoneurons (Fig. 1E). 
Functional reinnervation was confirmed by muscle force measurements on the reinnervated muscles
3 months after the avulsion injury. In the AR rats that did not receive a graft, only 5 ± 0.6 motor
units were detected in the EDL, and 6 ± 1 motor units in the TA muscle (Figs. 1F,H). In contrast, in
the animals that also received an iPSC graft,  15 ± 0.8 axons were found to innervate the EDL
muscle, and 17 ± 0.7 reached the TA muscle via the reimplanted ventral root (Figs. 1F,H). The
presence of a greater number of motor units in the grafted rats allowed the production of a larger
force by the reinnervated muscles.  In the control  rats,  the maximal  tetanic  tension (% ratio  of
operated side/intact side) was 11.9 ± 4.2% for the EDL muscle and 6 ± 2.2% for the TA muscle,
while the grafted animals produced significantly more tension (50.0 ± 2.1 % for the EDL muscle
and 53.2 ± 4.1 % for the TA muscle; Figs. 1G,I).
Differentiation of grafted iPSCs in the host cord
The grafted iPSCs formed a large cluster in the L4 segment 3 and 7 days after transplantation and
expressed the embryonic stem cell marker stage-specific embryonic antigen-1 (Figs. 2A and S2A).
The grafted  iPSCs did not  exhibit  any sign of  differentiation  on day 3 postoperatively, i.e.  no
mouse-specific  glial  or  neuronal  markers  were  expressed  by the  grafted  cells.  On  day 7  after
grafting  the  transplanted  iPSCs  started  to  differentiate  into  neurons  and  astrocytes,  but  not
oligodendrocytes (Figs. 2B,C). The iPSC-derived neurons expressed various neuronal markers (M6,
a mouse-specific neuronal marker, and approximately two-thirds of these expressed beta III-tubulin
too; Fig. S2B). The iPSC-derived astrocytes expressed the mouse-specific astrocyte marker M2, and
only a few M2-positive graft-derived astrocytes were additionally GFAP-positive (Fig. S2C). The
grafted cells had not migrated away from the graft 7 days after transplantation.  The graft-derived
beta III-tubulin-positive neurons and GFAP-positive astrocytes could mainly be detected at graft–
host interface, but the less differentiated M6-positive neurons and M2-positive astrocytes appeared
within the center of the graft too (Figs. 2B,C). 
By this time, the eGFP expression of the majority of the iPSC-derived neurons and astrocytes had
decreased or ceased, suggesting that the GFP expression pattern diminishes with differentiation. A
few iPSC-derived neurons and astrocytes did retain the ability to express eGFP strongly, but these
cells were found only within the center of the graft, not at the graft–host interface (Figs. 2B,C).
Quantification  of  the  differentiation  pattern  of  the  grafted  iPSCs  showed  that  3  days  after
transplantation approximately 50% of the iPSCs expressed the SSEA-1 marker, but this ratio was
halved by day 7 after transplantation (Fig. 2D).  The differentation of the grafted iPSCs continued
with time and on postoperative days 10, 12 and 16, the grafted cells had lost their eGFP expression
completely and decreasing numbers  of  iPSC-derived neurons and astrocytes  were  found in the
injured cord (Figs. 3A-D). 
On day 7  after  transplantation  29.6  ± 4.1% of  the  grafted  cells  was  identified  as  M2-positive
astrocytes and 31.4 ± 3.8% as M6-positive neurons, whereas by day 16 after transplantation these
numbers decreased to 3.7  ± 1.1% (M2) and 3.5 ± 0.6% (M6), respectively (Fig. 3E).
Microglia/macrophage reaction against iPSC-derived neurons and astrocytes
First we determined whether significant numbers of host cells invaded the territory of the grafted
iPSCs, a co-labeling with DAPI nuclear staining and GFP immunohistochemistry was performed.
We found  that  the  percentage  of  the  GFP+/DAPI+  cells  was  92.5  +-2%  in  7-day-old  grafts,
indicating  that  either  few host  cells  invaded the graft  or  not  all  the grafted  cells  were  able  to
maintain their GFP expression pattern by this survival time.
The differentiation of the grafted cells resulted in an altered antigen expression pattern on the cell
surface. On day 7 increased activation of microglia/macrophages could be observed around the graft
in the host cord (Fig. 4A). Numerous GSA-B4-positive cells were identified in the graft but these
cells were positive for GFP (Fig. 4B). At this time point the grafted cells started to differentiate to
M2-positive astrocytes and M6-positive neurons located at the graft-host interface. (Fig. 4C,D). Not
surprisingly  this  differentiating  cells  were  intermingled  with  GSA-B4-positive  macrophages
suggesting that differentiation of the grafted cells is accompanied by an attraction of macrophages
to the cell differentiation zone (Fig. 4C,D).  On days 10 and 12 after the avulsion injury, strong
reactions of the activated microglia/macrophages (GSA-B4-positive cells) could be detected in the
injured ventral horn and in the graft (Figs. 4E,F and Figs 5A,B). Microglia cells appeared around
the graft-derived neurons and astrocytes (Figs. S3A,B), suggesting that the presence of antigens on
the cell surface plays a very important role in cell recognition and elimination by macrophages. On
day 16 after grafting, the microglial activity was significantly decreased in the graft and in the
injured ventral horn, and there was a marked reduction in the number of grafted cells, too (Figs. 5C-
E). A strong reaction of the activated microglia was detected only close to the pial surface (Figs.
5C,D), where the remaining M2 and M6-positive cells were located. On day 21 after grafting, the
transplanted cells  could  no longer  be found in  the spinal  cord and the microglial  reaction  had
diminished  (not  shown).  Quantification  of  microglia/macrophage  reaction  revealed  a  dramatic
increase 10 and 12 after transplantation in the graft with significantly lower densities of GSA-B4-
positive macrophages at days 7 and 16 postoperatively (Fig. 5E). 
Transplantation of iPSCs delays injury-related astrocyte reaction
Astrocytes and microglia play a pivotal role in the removal of degenerating motoneurons after an
avulsion injury. The glial reactions were therefore analyzed in the injured spinal cords of the AR
and the AR+iPSCs animals in the first 7 postoperative days, a period known to be critical for the
injured  motoneurons.  The  densities  of  astrocytes  and  microglia  were  measured  rostrally  and
caudally  to  the  injury in  the  injured  ventral  horn.  On  day 3,  a  significantly  lower  density  of
microglia  was  detected  only  1  mm  rostrally  and  0,5  mm  caudally  to  the  central  site  of  the
avulsion/reimplantation injury (Figs. 6A,B). On day 7 after the injury, no significant difference in
microglial density was detected between the experimental groups (Figs. 6E,F). On the other hand,
on day 3 after the avulsion injury the astroglial reaction was significantly weaker in the AR+iPSCs
group than  in  the  control  (AR)  animals  (Figs.  6C,D).  By day 7  postoperatively, the  astroglial
reaction had increased in the grafted animals and the astrocyte density closely approached or even
reached that in the injured hemicord of the AR animals (Figs. 6G,H).
Determination of neurotrophic factors and cytokines in the affected segment
A semiquantitative PCR analysis was performed to determine the factors that act  in the grafted
spinal cords. Neurotrophic and immune factors known to play roles in spinal cord injuries ( Klusman
and Schwab, 1997  ) and their experimental treatment.  mRNA levels of both mouse and rat gene
products  were evaluated  in  samples  taken from the L4 segment  of  the AR and the AR+iPSCs
animals and from iPSC cultures. No differences were found between the AR and the AR+iPSCs
animals (n=4 in each group) in the mRNA levels of BDNF, IL-4, IL6, IL-18, and NT-3 (data not
shown) on days 3 and 7 following surgery, but the mRNA levels of NT-4, GDNF,  IL-1a, IL-10,
MIP-1a and TNF-a were significantly higher in the samples of the the AR+iPSCs animals than in
those from the AR animals at one or both postoperative time points (Figs. 7A-F). However, only the
mRNA levels  of  NT-4 and IL-10 were  significantly higher  in  the  AR+iPSCs animals  on  both
postoperative days 3 and 7 as compared with the levels in the AR animals (Figs. 7A,C). Of the 6
factors, IL-10 was the only one that demonstrated no detectable mRNA level in control animals
(Fig. 7C) and only NT-4 mRNA could be proven to be produced by the native murine iPSCs (Fig.
7A). 
Protein expression pattern of neurotrophic factors and cytokines in the grafted cells and in the
injured ventral horn
To test  whether  the mRNAs of  these factors  are  translated into protein production,  the protein
expressions of these cytokines and neurotrophic factors were studied with immunohistochemistry
through the use of mouse/rat-specific antibodies. 
On  day 3  after  grafting,  NT-4,  GDNF, IL-10  and  MIP-1a  were  found  to  be  expressed  in  the
AR+iPSCs animals (Figs. 7G-N). NT-4 expression was confined to the grafted iPSCs (Fig. 7K),
whereas the other 3 factors were expressed by both the transplanted iPSCs and the host tissue, with
seemingly similar expression intensity in the graft and host tissues (Figs. 7L-N).
On  postoperative  day  7,  the  protein  expressions  of  NT-4,  GDNF,  IL-10  and  MIP-1a  were
maintained. NT-4 was expressed weakly and its expression was restricted to the center of the graft
as it was not detected in the host tissue (Fig. 8A). The expression of GDNF was stronger than that
of  NT-4 in  the  graft  and  could  be  detected  in  the  host  tissue  too  (Fig.  8B).  The  strong
immunoreactivity of IL-10 and MIP-1a was found both in the graft and in the host tissue (Figs.
8C,D). Surprisingly, IL-1a and TNF-alpha were expressed in the host tissue, but not in the grafted
iPSCs (Figs. 8E,F). 
We examined the protein production in the injured ventral horns both of the AR and the AR+iPSCs
animals with a view to determining the cellular origin of these factors in the host tissue. Only the
astrocytes in the ventral horns of AR+iPSCs animals expressed GDNF on days 3 and 7 after the
injury (Figs. S4A,B). IL-10 was expressed both by the astrocytes and by the neurons on days 3 and
7 in the AR+iPSCs group (Figs. S4C,D). MIP-1a was expressed by the neurons, the astrocytes and
some microglia cells on days 3 and 7 postoperatively in the AR group (Figs. S5A,C and S6A,C).
Similarly, on day 3 postoperatively, the neurons, the astrocytes and a few microglia cells expressed
MIP-1a in the AR+iPSCs animals (Fig. S5B), while the expression of this cytokine had become
restricted  to  the  neurons  and  the  astrocytes  by postoperative  day 7  (Figs.  S5D and  S6D).  On
postoperative  day 7,  TNF-alpha  was  produced only by the  astrocytes  and the  microglia  in  the
AR+iPSCs animals  (Figs.  S7A,B),  while  IL-1a  was weakly expressed  by the  astrocytes  of  the
grafted animals (Fig. S8). 
The percentage of GFP/DAPI-positive grafted cells expressing the different neurotrophic factors
and cytokines  was determined 3 and 7 days  after  transplantation.  Quantification of  the  protein
expression patterns of the grafted iPSCs showed that all the four factors were expressed by more
than 60% of the grafted cells 3 days after transplantation (Fig. 8G, NT-4: 62.2 ± 2.6%; GDNF: 66.9
± 4.2%;  IL-10: 70.1 ± 4.7% and MIP-1a: 69.1 ± 10%).  Significant decrease in the percentage of
secreting cells was observed in the cases of NT-4 and IL-10 (43.1± 5.6% vs 49.5 ± 4.2%) by day 7
postoperatively, whereas only moderate decrease in the expression of GDNF and MIP-1a was seen
(57.2  ± 15.7% vs 58.8 ± 1.9%).
Discussion
The transplantation of iPSC-derived neural progenitor cells  is  of great promise as concerns the
promotion of functional recovery, particularly in the acute and sub-acute phases after a CNS injury.
(Fujimoto et al., 2012; Nori et al., 2011; Nutt et al., 2013). As far as we are aware, this is the first
study that has provided evidence that transplanted murine iPSCs are able to rescue large numbers of
motoneurons after  an avulsion  injury, these motoneurons being otherwise destined to  die.  This
survival of the injured motoneurons resulted in the functional reinnervation of the denervated hind
limb muscles, i.e. the rescued motoneurons were able to send their axons via the reimplanted ventral
root  and peripheral  nerve  pathways  and reinnervate  the target  muscle  fibers.   These beneficial
effects were achieved despite the fact that xenogeneic cells were transplanted into the rat spinal
cord.   It  may be assumed that  the grafted cells  exerted their  effect  during the first  week after
grafting,  while  they  were  undifferentiated  and  the  damaged  motoneurons  survived  and  were
susceptible  for  the  paracrine  effects  of  the  stem cells.   It  could  be  argued  that  the  molecular
therapeutic principles gained from these experiments and not the cross-species transplantation can
be translated and introduced into the therapeutic arsenal of human plexus injuries.    Moreover, it
should be noted that the very long distances that the regenerating axons of rescued motoneurons
should travel in humans may limit the success of such a strategy. 
Studies  by Carlstedt  and others  have  provided evidence  that  some of  the  injured motoneurons
survive  after  an  avulsion  injury  and  their  axons  grow  along  the  reimplanted  ventral  root  and
peripheral nerve pathways (Carlstedt et al., 1986; Nogradi and Vrbova, 1996; Nogradi and Vrbova,
2001). The spontaneous reinnervating capacity of the damaged motoneurons is limited and thus
they are not able to achieve satisfactory reinnervation of the target muscles when they have to
regenerate their axons along lengthy predegenerated nerve pathways (Eggers et al., 2010; Nogradi
and Vrbova, 2001). The application of riluzole, a compound possessing combined Na+ channel-
blocking  and  presynaptic  glutamate  release-inhibiting  effects,  proved  to  induce  a  successful
reinnervation  of  denervated  muscles,  involving up to  67% of  the  injured  L4  motoneuron  pool
(Nogradi and Vrbova, 2001; Nogradi et al., 2007). A number of studies have revealed that damaged
motoneurons can also be rescued by locally applied neurotrophic factors or by grafted stem or
neural progenitor cells, producing neurotrophic factors after avulsion-induced motoneuron injury
(Blits et al., 2004;  Eggers et al., 2008;  Hell RC, 2009;  Su H, 2009). However, motoneurons that
were rescued by a mechanism induced purely by neurotrophic factors were usuallly not able to
grow  their  axons  into  the  reimplanted  ventral  root  and  produce  functional  reinnervation  of
peripheral targets.
Recent work from our laboratories has shown that intraspinal or intraradicular application of the
clonal neuroectodermal stem cell  line NE-GFP-4C induced not only the survival of the injured
motoneurons after a ventral root injury but also extensive reinnervation of the denervated hindlimb
muscles by the regenerating axons (Pajenda et al., 2013).
In  the  present  study, we  transplanted  murine  iPSCs  produced  by a  novel  recombinant  protein
method (Nemes et al., 201  4).  In the first week after grafting, only minor phenotypic changes were
observed, and this period of slow differentiation and migration of the grafted cells coincided with
the intense gene expression profile of neurotrophic factors and cytokines and with the critical period
of motoneuron vulnerability, when motoneurons can be rescued. 
Interestingly, during this period of days after grafting, the majority of the iPSC-derived neurons lost
the eGFP signal,  and those which still  expressed the fluorescence reporter  protein  tended to b
located in the center of the graft rather than at the host–graft interface. By day 16, all the iPSC
derivatives had lost the eGFP expression.
One explanation for the eGFP signal loss might be that, during the  in vivo differentiation of the
grafted cells, the EF1α promoter is gradually and/or partially silenced. During the  in vitro neural
differentiation, we did not observe diminution of the eGFP signal, suggesting that, in the course of
the  in vitro and  in vivo differentiation of the eGFP-iPSCs, the signalling pathways are modulated
differently by the microenvironment in which the differentiation takes place. 
After  the  early  phase,  the  grafted  iPSCs  underwent  a  relatively  fast  differentiation  process,
accompanied by an intense and increasing microglial response, resulting in rapid elimination of the
grafted iPSCs by day 21 after grafting.  It may be argued that this fast cell differentiation and the
features  of  the  recombinant  protein-based iPSC production  result  in  the  early presence  of  cell
surface antigens, leading to the rapid elimination of the grafted cells by the host immune system.  
Following ventral root avulsion, the first 10-12 days is the most critical period for the survival of rat
motoneurons (Koliatsos  et  al.,  1994  ).  In  this  short  period,  injured motoneurons can respond to
rescuing strategies if treatment is started within 10 days after avulsion (Nogradi et al., 2007). The
grafted iPSCs produced two neurotrophic factors, NT-4 and GDNF, and the cytokines IL-10 and
MIP-1-alpha in the first 7 days after grafting. Moreover, injured ventral horn neurons and glial cells
express various cytokines and neurotrophic factors, indicating a strong signaling and modulatory
process in the injured ventral horn. The role of GDNF in motoneuron survival is well established.
Various studies have shown that the application of GDNF induced motoneuron survival following
ventral root avulsion and reimplantation, accompanied by sprouting of the regenerating axons and
nerve coil formation in the ventral root, but the injured motoneurons failed to send their axons into
the reimplanted root (Blits et al., 2004; Eggers et al., 2008; Wu et al., 2003).  Recent results from
our  laboratories  have  shown  that,  spatiotemporally  limited  engineered  expression  of  the
neurotrophic factors BDNF and/or GDNF results in relatively good motoneuron survival and target
reinnervation (Pajenda et al., 2014  ).  Others have suggested a synergistic effect between GDNF and
riluzole on the functional recovery following ventral root avulsion (Bergerot et al., 2004).  NT-4/5 is
reportedly a high-affinity ligand for the TrkB receptor (Minichiello et al., 1998). Signaling through
the TrkB receptor activates numerous intracellular pathways that may promote cytoplasmic and
nuclear  events  that  induce  neuronal  survival,  but  the  precise  role  of  NT4/5  in  neuronal  (more
specifically, motoneuron) survival needs to be confirmed.   
On  the  other  hand,  the  grafted  iPSCs  produced  the  anti-inflammatory  IL-10  and  the  pro-
inflammatory MIP-1-alpha.  IL-10 is known to initiate various signaling cascades through the IL-10
receptor in spinal cord neurons  in vitro,  thereby preventing the cell death otherwise induced by
glutamate  excitotoxicity  (Bachis  et  al.,  2001;  Zhou  et  al.,  2009a;  Zhou  et  al.,  2009b).  The
application of IL-10 after a spinal cord injury reportedly prevented neuronal death by inhibiting
caspase-3 cleavage (Jackson et al., 2005; Zhou et al., 2009a). 
In addition to the expression of the above factors by the grafted and host cells, the pro-inflammatory
cytokines IL-1-alpha, and TNF-alpha were produced only by the cells of the host spinal cord but not
in the grafted cells.  The mechanisms of action of IL-1-alpha, MIP-1-alpha and  TNF-alpha in the
CNS are not  yet  fully understood (Aldskogius,  2011;  Glezer  et  al.,  2007;  Juttler  et  al.,  2002).
Recent  data  provided  evidence  that  IL-1-alpha  and  TNF-alpha  are  neuroprotective  against
excitotoxicity-induced cell death in the CNS via distinct pathways (Carlson et al., 1998; Carlson et
al., 1999).  Moreover, the administration of IL-1-beta, IL-6 and TNF-alpha to the injured murine
spinal cord induced decreased levels of microglial activation and tissue loss (Klusman and Schwab,
1997).  MIP-1-alpha acts as a pro-inflammatory cytokine in the peripheral immune system, and its
role in regulation/signaling in the injured CNS is not well understood.  It could be argued that the
co-expression of these two, seemingly antagonistic groups of cytokines may result in an enhanced
effect on the downregulation of microglial and astroglial reactivity.  It was surprising to find that the
humoral  secretion  pattern  of  the  grafted  iPSCs  shows  both  similarities  and  differences  when
compared with the expression pattern of grafted NE-GFP-4C neuroectodermal stem cells in the
same injury model (Pajer et al. 2014). The NE-GFP-4C cells produced 5 modulatory cytokines (IL-
1-alpha, IL-6, IL-10, TNF-alpha and MIP-1-alpha), but not neurotrophic factors and this cytokine
signalling resulted in an even more significant motoneuron survival and regeneration.  It may be
thought,  that  apart  from different  molecular  composition  of  the  graft  secretome,  other  factors,
including  the  rapid  differentiation  of  iPSCs  and  the  early  presence  of  surface  antigens  may
contribute to the differential effects on motoneuron survival and reinnervation of peripheral targets. 
Conclusions
Our  data  suggest  that  grafted  iPSCs  induce  a  firm  reinnervation  by  surviving  motoneurons
otherwise  destined  to  die  via  complex regulatory and signaling  mechanisms,  that  involve  both
cytokines and neurotrophic factors.  These mechanisms appear to involve interactions between the
grafted stem cells and the host tissue.  It further seems evident that these motoneuron-rescuing
mechanisms  are  very  fine-tuned  as  they  are  able  to  rescue  injured  motoneurons  and  enhance
regeneration of their axons without inducing axonal sprouting and aberrant reinnervation. 
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Figure legends
Figure 1. Reinnervation of hind limb muscles by motoneurons rescued by iPSCs.
A.  Schematic diagram of the surgical procedure, including the avulsion and reimplantation of the L4 ventral
root and the transplantation of iPSCs.  B.  Images of retrogradely labeled reinnervating (FB-positive) and
surviving  (ChAT-positive)  motoneurons  taken  from spinal  cords  of  AR and  AR+iPSCs  animals.   C-E.
Individual twitch contractions of motor units (MUs) and tetanic curves are shown. D. The extensor digitorum
longus (EDL) and the tibialis anterior (TA) muscles of AR+iPSCs rats are innervated by significantly higher
numbers of motor axons than are the muscles of the AR animals. The higher numbers of reinnervating motor
axons produced stronger maximal tetanic muscle contractions in the AR+iPSCs animals. Error bars, S.E.M.,
p<0.05. Scale bar in A: 100 µm.
Figure 2. Differentiation of grafted iPSCs and their derivatives
A.  Expression of embryonic stem cell marker stage-specific embryonic antigen-1 by the grafted iPSCs 7
days after  transplantation.  B and  C. iPSC-derived astrocytes  (M2) and neurons (M6) could be detected
mainly at the graft–host interface. Arrows show GFP and M6 colocalized cells in the graft. D. The majority
of the grafted iPSCs (52.5 ± 2.5%) expressed SSEA-1 3 days after transplantation. Significantly decreased
SSEA-1 expression was detected (25.9 ± 4.8%) 7 days after transplantation. * indicates significant difference
between the 3 days and 7 days data (p<0.05), n=4 at each time point. A: 100 μm, in the enlarged inset: 20
μm; in B and C: 100 μm, in the enlarged inset: 50 μm; in D: 200 μm, in the insets: 20 μm.
Figure 3. Derivatives of grafted iPSCs disappear from the spinal cord
A, B, C and D. On days 7, 10, 12 and 16 after grafting, iPSC-derived neurons and astrocytes, which have
lost their GFP expression were detected. A continuous decrease of M2-positive astrocytes and M6-positive
neurons is seen along with the survival and differentiation of the grafted cells. On day 16 after grafting, very
few iPSC-derived neurons and astrocytes were found in the injured cord.  E. Quantification M2- and M6-
positive cells 7, 10, 12 and 16 days after transplantation. * = significant difference between 7, 10, 12 and 16
days data; ** = significant difference between 10 and 12 days data, p<0.05, n=4 at each time point. Scale bar
in A: 250 μm B: 200 μm, in the insets D: 20 μm.
Figure 4. Microglia/macrophage reaction in the graft on days 7 after transplantation
A and B. On day 7 after transplantation, few GFP-positive grafted cells displayed GSA-B4 reactivity. Arrows
point  to  the  GFP/GSA-B4  co-labeled  grafted  cells  in  B.  C and  D. Activated  microglia/macrophages
appeared around the iPSC-derived M2- and M6-positive cells 7 days postoperatively. E and F. Ten days after
transplantation the activated microglia/macrophages showed very strong density within the graft and in the
ventral horn. (g = graft, h = host cord) Scale bar in A,B: 100 μm C: 25 μm and E: 100 μm and 25 μm; and in
F: 20 μm
Figure 5. Microglia/macrophage reaction in the graft on days 12 and 16 after transplantation
A and B. On days 12 after transplantation, the activated microglia/macrophages showed very strong density
within the graft and in the ventral horn. C and D. It can be seen that 16 days after grafting very few iPSC-
derived  neurons  and  astrocytes  were  detected  and  the  density  of  activated  microglia/macrophages  had
decreased in the ventral horn, but increased around the surviving graft-derived cells.  E.  Quantification of
density of GSA-B4 reactivity within the graft. Significant increase of the GSA-B4 density is seen 10 and 12
days  after transplantation compared with the 7 days and 16 days data. * = significant difference between the
10, 12 and the 7, 16 days data; ** = significant difference between 7 and 16 days data, p<0.05, n=4 at each
time point. Scale bar: in A: 100 μm and 25 μm; and in B: 20 μm 
Figure 6. Astrocytic and microglial/macrophage reactions in injured ventral horns of the AR and the
AR+iPSCs groups.
A-D. Microglial/macrophage (A, B: GSA B4-positive) and astroglial (C, D: GFAP-positive) densities are
shown in  spinal  segment  L4  of  the  AR and the  AR+iPSCs animals  3  days  after  transplantation.  E-H.
Microglial  (E, F: GSA B4-positive) and astroglial  (G, H: GFAP-positive) densities are shown in spinal
segment L4 of the AR and the AR+iPSCs animals 7 days after grafting. Asterisks indicate the significant
differences in density between AR and iPSC animals at various distances from the site of avulsion. Error
bars, S.E.M., p<0.05. B, F, D and H. Examples of transverse sections 500 μm cranially to the avulsion site
processed for GFAP immunohistochemistry or GSA B4 isolectin histochemistry. Scale bar in B,D,F,H: 100
µm.
Figure  7.  Elevated mRNA levels (survival times 3 and 7 days ) and immunohistochemical detection
(survival time 3 days) of neurotrophic factors and cytokines
A-F. Relative gene expression levels of various cytokines in the ventral horns of the AR and the AR+iPSCs
animals and in native (non-grafted) cultured protein-based murine iPSCs.  There were significant higher
mRNA levels of all factors of the AR+iPSCs animals by 7 days after grafting relative to the AR data.  Only
the NT-4/5 mRNA levels of the grafted L4 segments were significantly different relative to their controls at 3
days.  IL-10 was produced only in the grafted cords, and the native murine iPSCs produced only NT4/5 in
detectable amounts. G-J. Immunohistochemical detection of the factors produced by the grafted cells and the
host cord at 3 days after transplantation. Note the ventral location of the graft. Insets are confocal images
taken at  various  optical  thickness  settings.   K-N. High-magnification epifluorescence photographs taken
from the graft–host interface.  Only NT4/5 is not detectable in the host cord around the graft, while the other
3 factors are expressed by both the host and the grafted tissue (g = graft, h = host).  Data are presented as
means ± S.E.M, p<0.05. One-way ANOVA analysis with Tukey's post-hoc test was used.  Scale bar in G-J:
250 µm and 100 µm in insets; in K-N: 50 µm.
Figure 8. Immunohistochemical detection of the produced factors 7 days after transplantation. 
A. NT-4/5 expression pattern is shown in the grafted cells. B-D. GDNF, IL-10 and MIP-1a are expressed by
the grafted iPSCs (graft=g) and host  (h) tissue.  Framed areas  are  enlarged in  A'-D'.   E and  F. Protein
expression  of  IL-1a  and  TNF-alpha  were  detected  only in  the  host  tissue.  G.  Secretion  pattern  of  the
neurotrophic factors NT-4/5 and GDNF and that of the cytokines IL-10 and MIP-1a shows more than 60% of
the DAPI+/GFP+ grafted cells express these factors on day 3 with a significant decrease by day 7 in the
cases of NT-4/5 and IL-10. * = significant difference between 3 and 7 days data; p<0.05, n=5 at each time
point. Scale bar in A-D: 200 µm; in A'-D' and in E-F: 150 µm.
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